Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, discuss the updates with targeted therapy as it relates to the early-stage setting of non–small cell lung cancer as well as those who harbor EGFR exon 20 insertion mutations.

Funding from Daiichi Sankyo/Content Independently Developed by OncLive

Thoracic Night Live

Thoracic Night Live is a hybrid video program devoted to spotlighting the biggest topics in lung cancer and pivotal studies discussed at medical meetings throughout the year. Episodes have focused data that were presented during the ASCO Annual Meeting, ESMO Congress, World Conference on Lung Cancer, and New York Lung Cancer Symposium, among other conferences.


Reflections on the Pivotal Lung Cancer Data of 2021

Josh Sabari, MD; Nicholas C. Rohs, MD; and Balazs Halmos, MD, discuss the updates with targeted therapy as it relates to the early-stage setting of non–small cell lung cancer as well as those who harbor EGFR exon 20 insertion mutations. 

 

Revolutionizing Targeted Therapy With EGFR Exon 20 and the Early-Stage NSCLC Setting